CN110801469A - 一种调节血糖的功能性食品及其制备方法 - Google Patents
一种调节血糖的功能性食品及其制备方法 Download PDFInfo
- Publication number
- CN110801469A CN110801469A CN201911043632.5A CN201911043632A CN110801469A CN 110801469 A CN110801469 A CN 110801469A CN 201911043632 A CN201911043632 A CN 201911043632A CN 110801469 A CN110801469 A CN 110801469A
- Authority
- CN
- China
- Prior art keywords
- parts
- ginkgo
- functional food
- extract
- blood sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 69
- 235000013376 functional food Nutrition 0.000 title claims abstract description 50
- 210000004369 blood Anatomy 0.000 title claims description 86
- 239000008280 blood Substances 0.000 title claims description 86
- 238000002360 preparation method Methods 0.000 title abstract description 22
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 58
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 57
- 201000001421 hyperglycemia Diseases 0.000 claims abstract description 49
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 45
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 45
- 240000000249 Morus alba Species 0.000 claims abstract description 42
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 42
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 38
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 38
- 235000008434 ginseng Nutrition 0.000 claims abstract description 38
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 35
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 35
- 241000117280 Naematelia aurantialba Species 0.000 claims abstract description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 85
- 241000208340 Araliaceae Species 0.000 claims description 38
- 238000000605 extraction Methods 0.000 claims description 38
- 238000002156 mixing Methods 0.000 claims description 23
- 239000000706 filtrate Substances 0.000 claims description 22
- 239000002994 raw material Substances 0.000 claims description 21
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 18
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 18
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 18
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 18
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 17
- 239000012535 impurity Substances 0.000 claims description 17
- 238000000855 fermentation Methods 0.000 claims description 15
- 230000004151 fermentation Effects 0.000 claims description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 12
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 229920002261 Corn starch Polymers 0.000 claims description 11
- 239000008120 corn starch Substances 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 238000002791 soaking Methods 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- 229920001282 polysaccharide Polymers 0.000 claims description 10
- 239000005017 polysaccharide Substances 0.000 claims description 10
- 150000004676 glycans Chemical class 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 229920002774 Maltodextrin Polymers 0.000 claims description 6
- 239000005913 Maltodextrin Substances 0.000 claims description 6
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 6
- 235000013361 beverage Nutrition 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000007888 film coating Substances 0.000 claims description 6
- 238000009501 film coating Methods 0.000 claims description 6
- 235000019359 magnesium stearate Nutrition 0.000 claims description 6
- 229940035034 maltodextrin Drugs 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 239000000377 silicon dioxide Substances 0.000 claims description 6
- 235000012239 silicon dioxide Nutrition 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 108010059892 Cellulase Proteins 0.000 claims description 5
- 229940106157 cellulase Drugs 0.000 claims description 5
- 230000001276 controlling effect Effects 0.000 claims description 5
- 230000005484 gravity Effects 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 241000218628 Ginkgo Species 0.000 claims 12
- 244000194101 Ginkgo biloba Species 0.000 abstract description 49
- 230000036541 health Effects 0.000 abstract description 7
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 31
- 206010012601 diabetes mellitus Diseases 0.000 description 25
- 230000001603 reducing effect Effects 0.000 description 22
- 239000003814 drug Substances 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 238000011160 research Methods 0.000 description 16
- 235000013305 food Nutrition 0.000 description 12
- 235000019197 fats Nutrition 0.000 description 11
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 230000001976 improved effect Effects 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 206010022489 Insulin Resistance Diseases 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 230000000144 pharmacologic effect Effects 0.000 description 7
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 229940089161 ginsenoside Drugs 0.000 description 5
- 229930182494 ginsenoside Natural products 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 210000004153 islets of langerhan Anatomy 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 230000032258 transport Effects 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 241001506047 Tremella Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- CDAISMWEOUEBRE-LKPKBOIGSA-N 1D-chiro-inositol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-LKPKBOIGSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 2
- 241000219051 Fagopyrum Species 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000033679 diabetic kidney disease Diseases 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- YLKVIMNNMLKUGJ-FPLPWBNLSA-N (15:1)-Cardanol Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1 YLKVIMNNMLKUGJ-FPLPWBNLSA-N 0.000 description 1
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- YXHVCZZLWZYHSA-UHFFFAOYSA-N (Z)-6-[8-pentadecenyl]salicylic acid Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-UHFFFAOYSA-N 0.000 description 1
- YLKVIMNNMLKUGJ-UHFFFAOYSA-N 3-Delta8-pentadecenylphenol Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1 YLKVIMNNMLKUGJ-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000380450 Danaus melanippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000218791 Ginkgoaceae Species 0.000 description 1
- YXHVCZZLWZYHSA-FPLPWBNLSA-N Ginkgoic acid Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-FPLPWBNLSA-N 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 229940122355 Insulin sensitizer Drugs 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 241000221365 Tremellales Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000007885 bronchoconstriction Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- -1 lead Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008621 organismal health Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
- A23L2/395—Dry compositions in a particular shape or form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明实施例提供一种调节高血糖的功能性食品及其制备方法,涉及保健品技术领域,该调节血糖的功能性食品经体内动物功能试验证明,具有辅助降血糖的保健功能,并且能够有效调节血糖、且安全有效,无毒副作用。该调节高血糖的功能性食品包括以下份数的有效成分:金耳8‑12份、桑叶10‑12份、白果12‑16份、葛根8‑12份、银杏叶15‑20份、苦荞2‑8份、人参2‑12份。
Description
技术领域
本发明涉及保健品技术领域,具体涉及一种调节血糖的功能性食品及其制备方法。
背景技术
近年来,随着人们生活水平的提高和饮食结构的改变,糖尿病发病率正在迅速上升,现已成为仅次于心脑血管病和肿瘤的第三大危害性疾病,严重威胁病人的健康和生命。据报道,发达国家糖尿病发病率约为6%-10%,我国糖尿病发病率约为2%-4%。2002年我国患者已接近4000万,居世界第二。截止2004年,全世界已有1.51亿患者。糖尿病引起的并发症严重影响了机体健康,目前其治疗方式主要为药物治疗;药物治疗虽然起效较快,但都具有一定程度的副作用,对中老年人的生活质量有一定的影响,在宏观和微观经济层面,糖尿病及其并发症通过直接医疗费用及工作和工资损失给糖尿病患者及其家庭、卫生系统和国家经济造成巨大经济损失。使低收入和中等收入国家及家庭的经济背上了沉重负担;同时,在此亚健康时代,随着人们对自身健康的关注度升高,未病先防已深入人心。因此,功能性食品及保健食品已经开始成分人们调节自身健康的一种手段。
目前,市面上调节血糖的产品众多,同时,由于糖尿病严重后而引起的并发症发病率逐年上升,但市面上降糖的产品过大宣传产品功效,且产品质量良莠不齐,作用途径不清晰,严重误导消费者,对其身体和心理带来伤害,而糖尿病疾病日趋增长,严重影响了人群的生活质量,因此,开发一款具有一定调节血糖的功能性食品已成为一种市场趋势。虽然,市面上调节血糖的产品众多,同时,由于糖尿病引发的并发症发病率逐年上升,但市面上辅助降血糖的产品过大宣传产品功效,且产品质量良莠不齐,作用途径不清晰,严重误导消费者,对其身体和心理带来伤害,而糖尿病疾病日趋增长,严重影响了人群的生活质量,为了解决上述问题,本发明提供了一种调节高血糖的功能性食品及其制备方法,所述调节高血糖的片剂和固体饮品,确保了产品的功效,制备方法具有易于工业化,适应范围广等特性。为此,需要设计相应的技术方案给予解决。
发明内容
针对上述缺陷,本发明的目的是提供一种调节血糖的功能性食品及其制备方法,解决了上述背景技术存在的问题,满足实际应用需求。
本发明是通过以下技术方案实现的:
一种调节血糖的功能性食品,所述功能性食品包括以下份数的有效成分:金耳8-12份、桑叶10-12份、白果12-16份、葛根8-12份、银杏叶15-20份、苦荞2-8份、人参2-12份。
作为上述技术方案的改进,所述功能性食品包括以下份数的有效成分:金耳10份、桑叶11份、白果14份、葛根10份、银杏叶18份、苦荞5份、人参7份。
作为上述技术方案的改进,所述调节血糖的功能性食品的制备方法如下:
步骤1、根据配合比和制造量选择适当量的金耳、桑叶、白果、葛根、银杏叶、苦荞、人参;
步骤2、将上述桑叶、葛根、苦荞去杂,然后用乙醇回流提取,收集滤液,浓缩,得浸膏1;
步骤3、以固体金耳实体为对象,采用纤维素酶提取方法,获得金耳发酵液(为多糖);
步骤4、将白果、银杏叶去杂,乙醇提取,收集滤液,浓缩,得浸膏2;
步骤5、将上述浸膏1、金耳发酵液、浸膏2混合均匀,比重控制在0.8-1.2,后进行喷雾干燥,得混合提取物;
步骤6、将人参去杂质,切断,用粉碎仪进行粉碎,粉末过80目筛网;
步骤7、将人参粉末、浸膏1、金耳发酵液及浸膏2混合,制成降糖片剂及降糖固体饮品功能食品。
作为上述技术方案的改进,上述所述步骤(2)中的水煮法提取桑叶、葛根、苦荞有效成分的具体步骤为:
(2.1)将桑叶、葛根、苦荞三种原料按特定比例取料,置多功能提取罐中;
(2.2)在多功能提取罐中加75%乙醇,料液比为1:8:13,浸泡1-2h;
(2.3)加温至沸腾,提取2次,1.5h/次;
(2.4)过滤,收集滤液,65℃减压浓缩,得浸膏1。
作为上述技术方案的改进,上述所述步骤(4)的醇提法提取白果、银杏叶的有效成分的具体步骤为:
(4.1)白果、银杏叶两种原料按特定比例取料,置多功能提取罐中;
(4.2)在多功能提取罐中加入75%乙醇,料液比为1:8,浸泡0.5-1h;
(4.3)加温至沸腾,提取3次,1.5h/次;
(4.4)过滤,收集滤液,65℃减压浓缩,得浸膏2。
作为上述技术方案的改进,所述调节血糖的功能性食品的制备方法包括:
(a)将六种原料制备的粉状物86份,混合均匀,加入75份玉米淀粉、45份麦芽糊精、0.5份羟丙甲基纤维素混合均匀;
(b)称取4.5份羟丙甲基纤维素加入90%乙醇制成10%的羟丙甲基纤维素溶液,备用;
(c)将(a)中混合粉末加入(b)中粘合剂,14目筛网制粒;
(d)烘箱温度调至55℃,干燥1-3h;
(e)干燥颗粒于14目筛网进行整粒,后外加2份硬脂酸镁和2份二氧化硅,进行总混;
(f)颗粒进行压片,调整片重为0.6g/片,进行薄膜包衣,铝塑包装,即得调节高血糖片剂功能食品。
本发明所述金耳为真菌植物门真菌,又称黄木耳、茂若色尔布(藏语)、金黄银耳、黄耳、脑耳,金耳的滋补营养价值优于银耳、黑木耳等胶质菌类,是一种理想的高级筳宴佳肴和保健佳品。
银杏果,含有多种营养元素,除淀粉、蛋白质、脂肪、糖类之外,还含有维生素c,核黄素、胡萝卜素、钙、磷、铁、钾、镁等微量元素,以及银杏酸、白果酚、五碳多糖、脂固醇等成分。具有益肺气、治咳喘、止带浊、缩小便、平皴皱、护血管、增加血流量等食疗作用和医用效果。根据现代医学研究,银杏还具有通畅血管、改善大脑功能、延缓老年人大脑衰老、增强记忆能力、治疗老年痴呆症和脑供血不足等功效,银杏抗衰老的本领在德国和法国的科学影响很大。此外,银杏果还可以保护肝脏、减少心律不齐、防止过敏反应中致命性的支气管收缩,还可以应用于对付哮喘、移植排异、心肌梗塞、中风、器官保护和透析。当代食疗专家胡珍珠、窦国祥等,应用营养学和医药学原理,给食疗以科学的阐释和分析。他们的著述将祖国食疗这一济世异宝,进行了认真的继承、系统的整理,使传统的食疗文化大放异彩。保留在各种医著和流传在民间的食疗方剂,病人服之,不但疗病,并可充饥;不但充饥,更可适口。用之对症,病自渐愈;即不对症,亦无他患。诚为至稳善之方也。"
银杏叶,为银杏科植物银杏Ginkgo biloba L.的干燥叶,秋季叶尚绿时采收,及时干燥。一般为人工栽培。栽培地区北至辽宁,南达广东,东起浙江,西达陕西、甘肃、西南到四川、贵州、云南等地。具有活血化瘀,通络止痛,敛肺平喘,化浊降脂的功效。用于瘀血阻络,胸痹心痛,中风偏瘫,肺虚咳喘,高脂血症。
桑叶,是很好的保健食品原料,据现代药理研究:桑叶中有黄酮类,多糖类生物碱类,植物甾醇类具有降血糖,降血脂、降血压的功效;桑叶抑制血糖上升的作用机理与桑叶中丰富的氨基酸、维生素及多种生理活性物质有关,桑叶中的生物碱类中具有代表性的DNJ能抑制a-葡萄糖苷酶活性,从而抑制及延缓淀粉,食物分解为葡萄糖,果糖,抑制血糖上升;桑叶中的黄酮成分具有降血压、舒血管、清除自由基、抑制血清脂质增加和抑制动脉粥样硬化形成的活性,它与桑叶中富含的多糖、生物碱等成分在降血糖活性方面有很好的协同配伍作用,可通过刺激胰岛素释放、增加胰岛素敏感性、抑制α-糖苷酶、增加外周糖的利用等机制而起到降低血糖的作用。桑叶多糖具有显著的降血糖作用,在治疗Ⅱ型糖尿病上具有多项调节作用;研究发现:桑叶多糖对Ⅱ型糖尿病大鼠?GLUT4?mRNA,Resistin?mRNA?和Resistin?蛋白表达的影响,发现桑叶多糖可上调Ⅱ型糖尿病大鼠GLUT4 mRNA表达,下调Ⅱ型糖尿病大鼠Resistin?mRNA和Resistin蛋白的表达,从而实现其降血糖作用,同时桑叶中的多糖能改善糖耐量,抑制血脂升高,降低外周血清胰岛素水平,改善Ⅱ型糖尿病大鼠胰岛素抵抗,对治疗Ⅱ型糖尿病具有多项调节。
葛根,味甘、辛,性凉,有解表退热、生津透疹、升阳止泻之效。现代药理研究表明,葛根中所含黄酮类具有降糖作用,机制主要是促进胰岛B细胞分泌,作用缓慢而持久。实验研究表明静脉滴注葛根素能改善Ⅱ型糖尿病患者血糖控制状况,增加机体对胰岛素的敏感性。研究发现:35例早期糖尿病肾病患者基础治疗上加用葛根素注射液,血液流变学各项指标较治疗前显著下UAER、SCr、BUN均明显下降,可显著改善患者的血液流变性,减少尿白蛋白的排出,减轻肾损伤,改善肾功能。
苦荞,是一种起源于我国的一年或多年生草本或半灌木,寥科荞麦属。苦荞中含有丰富的蛋白质,脂肪酸、淀粉,膳食纤维及微量元素,如Cr3+含量丰富,它是构成“葡萄糖耐量因子”,可增强胰岛素功能的重要活性物质;苦荞中有特有的硒,其含量为它在人体中与金属结合形成不稳定的“金属一硒一蛋白质”复合物,可以排解人体中如铅、录、镉等有毒物质,还有抗氧化和调节免疫力能力。苦荞中含有糖醇类,苦荞中含有千分之几含量的D-手性肌醇(D-CI),是苦荞中一种主要的有降血糖活性的物质,可以由苦荞中含量较多的荞麦糖醇(含量为百分之几)转化而来,研究表明苦荞提取物可以降低小鼠淀粉蔗糖灌胃后的血糖,推测与降糖药(阿卡波糖)降糖原理一样,与提取物中含有葡萄糖苷酶抑制剂有关。苦荞提取物还能通过增加胰岛素受体数量来提高胰岛素与受体结合敏感性,促进组织摄取葡萄糖从而降低糖尿病小鼠的血糖值,作用原理是苦荞中含有糖醇类,D-CI在人体肠道微生物的降解下大量产生,对糖尿病患者由于胰岛素抵抗所缺乏的D-CI进行了补充。研究认为苦荞中黄酮通过激活过氧化物增殖剂激活受体来实现降糖等作用,且还与苦荞中蛋白复合物的清除过氧化物作用相关。
人参,为五加科植物人参属的根茎,为多年生草本植物,是驰名中外的名贵药材,人参具有多种祛病养生功效,人参虽然不能代替胰岛素,但是能够缓解症状,起到相当有利的辅助作用。人参尚有抗消渴病气阴虚疲劳和缺氧的作用。现代医药学研究发现,人参成分复杂,有降血糖功效的成分包括人参提取物、人参皂苷、人参多糖、人参多肽等;研究发现:在早期糖尿病肾病患者服药过程中加用人参总皂75mg/d,检测到患者尿微量白蛋白(提示肾脏功能异常)排泄量显著降低,同时发现患者并发症也减轻了。通过对糖尿病大鼠模型口服人参皂苷的实验证实,人参皂苷中的活性成分Re能显著降低实验动物血糖,其抗糖尿病效果良好,同时提高了葡萄糖耐受量能力。通过实验证实,人参皂苷中的Rb1、Rb2、Rb3也有降低血糖的作用,其作用与胰岛素增敏剂作用类似。研究表明,人参多糖给糖尿病模型小鼠腹腔注射?20?min后,即可检测到血清胰岛素含量的增加,对切除肾上腺的大鼠仍能降低其血糖和肝糖原。糖尿病患者在给予降糖药的同时注射人参皂苷后血中sIL-2R水平下降,而CD4/CD8、NK细胞活性显著增高。IgG、IgM是体液免疫反应的主要效应因子,给予糖尿病大鼠人参白虎汤则明显提高血清IgG、IgM的含量,人参醇提物也可降低糖尿病小鼠迟发型免疫反应。由此可以推测人参能通过调节机体免疫功能,改善机体一般状况,修复残存胰岛B细胞,达到降低血糖的目的。
本发明的有益效果:
(1)本发明提供的调节高血糖的片剂,其配方以中医基础理论为指导,同时结合现代药理研究,确保产品的功效。
(2)本发明提供的调节高血糖的片剂,其加入玉米淀粉,于服用的片剂制剂,提高产品的生物利用度,适合血糖偏高者服用,且便于携带和运输。
(3)本发明提供的调节高血糖的片剂,此配方经过体内降糖动物功效验证,证明此配方具有显著的降低高血糖的功效。
(4)本发明提供的调节高血糖的片剂,其方中精选各药为国家规定的药食同源原料,且用量上严格限制在一定范围(药典用量下限的2/3),安全有效,无毒副作用,可长期食用。
(5)本发明提供的调节高血糖的片剂,可预防糖尿病疾病,控制血糖,保护胰岛细胞,调节血脂,尤其对中老年人血糖偏高者,三高患者,具有显著功效。
(6)本发明提供的调节高血糖的功能性食品及其制备方法,其通过特定的有效成分,制备成具调节高血糖,生物利用度高,且便于携带和运输的片剂。
本发明制备方法具有构思新颖、工艺简单、受益显著,可以广泛应用于多类保健食品组合物的制备领域。
具体实施方式
实施例1:
一种调节血糖的功能性食品,所述功能性食品包括以下份数的有效成分:金耳8份、桑叶10份、白果12份、葛根8份、银杏叶15份、苦荞2份、人参2份。
所述调节血糖的功能性食品的制备方法如下:步骤1、根据配合比和制造量选择适当量的金耳、桑叶、白果、葛根、银杏叶、苦荞、人参;步骤2、将上述桑叶、葛根、苦荞去杂,然后用乙醇回流提取,收集滤液,浓缩,得浸膏1;步骤3、以固体金耳实体为对象,采用纤维素酶提取方法,获得金耳发酵液(为多糖);步骤4、将白果、银杏叶去杂,乙醇提取,收集滤液,浓缩,得浸膏2;步骤5、将上述浸膏1、金耳发酵液、浸膏2混合均匀,比重控制在0.8,后进行喷雾干燥,得混合提取物;步骤6、将人参去杂质,切断,用粉碎仪进行粉碎,粉末过80目筛网;步骤7、将人参粉末、浸膏1、金耳发酵液及浸膏2混合,制成降糖片剂及降糖固体饮品功能食品。
其中,所述步骤(2)中的水煮法提取桑叶、葛根、苦荞有效成分的具体步骤为:
(2.1)将桑叶、葛根、苦荞三种原料按特定比例取料,置多功能提取罐中;
(2.2)在多功能提取罐中加75%乙醇,料液比为1:8:13,浸泡1-2h;
(2.3)加温至沸腾,提取2次,1.5h/次;
(2.4)过滤,收集滤液,65℃减压浓缩,得浸膏1。
其中,所述步骤(4)的醇提法提取白果、银杏叶的有效成分的具体步骤为:
(4.1)白果、银杏叶两种原料按特定比例取料,置多功能提取罐中;
(4.2)在多功能提取罐中加入75%乙醇,料液比为1:8,浸泡0.5h;
(4.3)加温至沸腾,提取3次,1.5h/次;
(4.4)过滤,收集滤液,65℃减压浓缩,得浸膏2。
具体地,所述调节血糖的功能性食品的制备方法还包括如下操作:
(a)将六种原料制备的粉状物86份,混合均匀,加入75份玉米淀粉、45份麦芽糊精、0.5份羟丙甲基纤维素混合均匀;
(b)称取4.5份羟丙甲基纤维素加入90%乙醇制成10%的羟丙甲基纤维素溶液,备用;
(c)将(a)中混合粉末加入(b)中粘合剂,14目筛网制粒;
(d)烘箱温度调至55℃,干燥1h;
(e)干燥颗粒于14目筛网进行整粒,后外加2份硬脂酸镁和2份二氧化硅,进行总混;
(f)颗粒进行压片,调整片重为0.6g/片,进行薄膜包衣,铝塑包装,即得调节高血糖片剂功能食品。
本发明提供的调节高血糖的片剂,其配方以中医基础理论为指导,同时结合现代药理研究,确保产品的功效;本发明提供的调节高血糖的片剂,其加入玉米淀粉,于服用的片剂制剂,提高产品的生物利用度,适合血糖偏高者服用,且便于携带和运输;本发明提供的调节高血糖的片剂,此配方经过体内降糖动物功效验证,证明此配方具有显著降低高血糖的功效;本发明提供的调节高血糖的片剂,其方中精选各药为国家规定的药食同源原料,且用量上严格限制在一定范围(药典用量下限的2/3),安全有效,无毒副作用,可长期食用;本发明提供的调节高血糖的片剂,可预防糖尿病疾病,控制血糖,保护胰岛细胞,调节血脂,尤其对中老年人血糖偏高者,三高患者,具有显著功效;本发明提供的调节高血糖的功能性食品及其制备方法,其通过特定的有效成分,制备成具调节高血糖,生物利用度高,且便于携带和运输的片剂。
实施例2:
一种调节血糖的功能性食品,所述功能性食品包括以下份数的有效成分:金耳10份、桑叶11份、白果14份、葛根10份、银杏叶18份、苦荞5份、人参7份。
所述调节血糖的功能性食品的制备方法如下:步骤1、根据配合比和制造量选择适当量的金耳、桑叶、白果、葛根、银杏叶、苦荞、人参;步骤2、将上述桑叶、葛根、苦荞去杂,然后用乙醇回流提取,收集滤液,浓缩,得浸膏1;步骤3、以固体金耳实体为对象,采用纤维素酶提取方法,获得金耳发酵液(为多糖);步骤4、将白果、银杏叶去杂,乙醇提取,收集滤液,浓缩,得浸膏2;步骤5、将上述浸膏1、金耳发酵液、浸膏2混合均匀,比重控制在1.0,后进行喷雾干燥,得混合提取物;步骤6、将人参去杂质,切断,用粉碎仪进行粉碎,粉末过80目筛网;步骤7、将人参粉末、浸膏1、金耳发酵液及浸膏2混合,制成降糖片剂及降糖固体饮品功能食品。
其中,所述步骤(2)中的水煮法提取桑叶、葛根、苦荞有效成分的具体步骤为:
(2.1)将桑叶、葛根、苦荞三种原料按特定比例取料,置多功能提取罐中;
(2.2)在多功能提取罐中加75%乙醇,料液比为1:8:13,浸泡1.5h;
(2.3)加温至沸腾,提取2次,1.5h/次;
(2.4)过滤,收集滤液,65℃减压浓缩,得浸膏1。
其中,所述步骤(4)的醇提法提取白果、银杏叶的有效成分的具体步骤为:
(4.1)白果、银杏叶两种原料按特定比例取料,置多功能提取罐中;
(4.2)在多功能提取罐中加入75%乙醇,料液比为1:8,浸泡0.75h;
(4.3)加温至沸腾,提取3次,1.5h/次;
(4.4)过滤,收集滤液,65℃减压浓缩,得浸膏2。
具体地,所述调节血糖的功能性食品的制备方法还包括如下操作:
(a)将六种原料制备的粉状物86份,混合均匀,加入75份玉米淀粉、45份麦芽糊精、0.5份羟丙甲基纤维素混合均匀;
(b)称取4.5份羟丙甲基纤维素加入90%乙醇制成10%的羟丙甲基纤维素溶液,备用;
(c)将(a)中混合粉末加入(b)中粘合剂,14目筛网制粒;
(d)烘箱温度调至55℃,干燥2h;
(e)干燥颗粒于14目筛网进行整粒,后外加2份硬脂酸镁和2份二氧化硅,进行总混;
(f)颗粒进行压片,调整片重为0.6g/片,进行薄膜包衣,铝塑包装,即得调节高血糖片剂功能食品。
本发明提供的调节高血糖的片剂,其配方以中医基础理论为指导,同时结合现代药理研究,确保产品的功效;本发明提供的调节高血糖的片剂,其加入玉米淀粉,于服用的片剂制剂,提高产品的生物利用度,适合血糖偏高者服用,且便于携带和运输;本发明提供的调节高血糖的片剂,此配方经过体内降糖动物功效验证,证明此配方具有显著降低高血糖的功效;本发明提供的调节高血糖的片剂,其方中精选各药为国家规定的药食同源原料,且用量上严格限制在一定范围(药典用量下限的2/3),安全有效,无毒副作用,可长期食用;本发明提供的调节高血糖的片剂,可预防糖尿病疾病,控制血糖,保护胰岛细胞,调节血脂,尤其对中老年人血糖偏高者,三高患者,具有显著功效;本发明提供的调节高血糖的功能性食品及其制备方法,其通过特定的有效成分,制备成具调节高血糖,生物利用度高,且便于携带和运输的片剂。
实施例3:
一种调节血糖的功能性食品,所述功能性食品包括以下份数的有效成分:金耳12份、桑叶12份、白果16份、葛根12份、银杏叶20份、苦荞8份、人参12份。
所述调节血糖的功能性食品的制备方法如下:步骤1、根据配合比和制造量选择适当量的金耳、桑叶、白果、葛根、银杏叶、苦荞、人参;步骤2、将上述桑叶、葛根、苦荞去杂,然后用乙醇回流提取,收集滤液,浓缩,得浸膏1;步骤3、以固体金耳实体为对象,采用纤维素酶提取方法,获得金耳发酵液(为多糖);步骤4、将白果、银杏叶去杂,乙醇提取,收集滤液,浓缩,得浸膏2;步骤5、将上述浸膏1、金耳发酵液、浸膏2混合均匀,比重控制在1.2,后进行喷雾干燥,得混合提取物;步骤6、将人参去杂质,切断,用粉碎仪进行粉碎,粉末过80目筛网;步骤7、将人参粉末、浸膏1、金耳发酵液及浸膏2混合,制成降糖片剂及降糖固体饮品功能食品。
其中,所述步骤(2)中的水煮法提取桑叶、葛根、苦荞有效成分的具体步骤为:
(2.1)将桑叶、葛根、苦荞三种原料按特定比例取料,置多功能提取罐中;
(2.2)在多功能提取罐中加75%乙醇,料液比为1:8:13,浸泡2h;
(2.3)加温至沸腾,提取2次,1.5h/次;
(2.4)过滤,收集滤液,65℃减压浓缩,得浸膏1。
其中,所述步骤(4)的醇提法提取白果、银杏叶的有效成分的具体步骤为:
(4.1)白果、银杏叶两种原料按特定比例取料,置多功能提取罐中;
(4.2)在多功能提取罐中加入75%乙醇,料液比为1:8,浸泡1h;
(4.3)加温至沸腾,提取3次,1.5h/次;
(4.4)过滤,收集滤液,65℃减压浓缩,得浸膏2。
具体地,所述调节血糖的功能性食品的制备方法还包括如下操作:
(a)将六种原料制备的粉状物86份,混合均匀,加入75份玉米淀粉、45份麦芽糊精、0.5份羟丙甲基纤维素混合均匀;
(b)称取4.5份羟丙甲基纤维素加入90%乙醇制成10%的羟丙甲基纤维素溶液,备用;
(c)将(a)中混合粉末加入(b)中粘合剂,14目筛网制粒;
(d)烘箱温度调至55℃,干燥3h;
(e)干燥颗粒于14目筛网进行整粒,后外加2份硬脂酸镁和2份二氧化硅,进行总混;
(f)颗粒进行压片,调整片重为0.6g/片,进行薄膜包衣,铝塑包装,即得调节高血糖片剂功能食品。
本发明提供的调节高血糖的片剂,其配方以中医基础理论为指导,同时结合现代药理研究,确保产品的功效;本发明提供的调节高血糖的片剂,其加入玉米淀粉,于服用的片剂制剂,提高产品的生物利用度,适合血糖偏高者服用,且便于携带和运输;本发明提供的调节高血糖的片剂,此配方经过体内降糖动物功效验证,证明此配方具有显著降低高血糖的功效;本发明提供的调节高血糖的片剂,其方中精选各药为国家规定的药食同源原料,且用量上严格限制在一定范围(药典用量下限的2/3),安全有效,无毒副作用,可长期食用;本发明提供的调节高血糖的片剂,可预防糖尿病疾病,控制血糖,保护胰岛细胞,调节血脂,尤其对中老年人血糖偏高者,三高患者,具有显著功效;本发明提供的调节高血糖的功能性食品及其制备方法,其通过特定的有效成分,制备成具调节高血糖,生物利用度高,且便于携带和运输的片剂。
实施例4:
一种调节血糖的功能性食品,所述功能性食品包括以下份数的有效成分:桑叶12份、葛根12份、苦荞8份、人参12份。
所述调节血糖的功能性食品的制备方法如下:步骤1、根据配合比和制造量选择适当量的桑叶、葛根、苦荞、人参;步骤2、将上述桑叶、葛根、苦荞去杂,然后用乙醇回流提取,收集滤液,浓缩,得浸膏1;步骤3、将人参去杂质,切断,用粉碎仪进行粉碎,粉末过80目筛网;步骤4、将人参粉末、浸膏1混合,制成降糖片剂及降糖固体饮品功能食品。
其中,所述步骤(2)中的水煮法提取桑叶、葛根、苦荞有效成分的具体步骤为:
(2.1)将桑叶、葛根、苦荞三种原料按特定比例取料,置多功能提取罐中;
(2.2)在多功能提取罐中加75%乙醇,料液比为1:8:13,浸泡2h;
(2.3)加温至沸腾,提取2次,1.5h/次;
(2.4)过滤,收集滤液,65℃减压浓缩,得浸膏1。
具体地,所述调节血糖的功能性食品的制备方法还包括如下操作:
(a)将六种原料制备的粉状物86份,混合均匀,加入75份玉米淀粉、45份麦芽糊精、0.5份羟丙甲基纤维素混合均匀;
(b)称取4.5份羟丙甲基纤维素加入90%乙醇制成10%的羟丙甲基纤维素溶液,备用;
(c)将(a)中混合粉末加入(b)中粘合剂,14目筛网制粒;
(d)烘箱温度调至55℃,干燥3h;
(e)干燥颗粒于14目筛网进行整粒,后外加2份硬脂酸镁和2份二氧化硅,进行总混;
(f)颗粒进行压片,调整片重为0.6g/片,进行薄膜包衣,铝塑包装,即得调节高血糖片剂功能食品。
本发明提供的调节高血糖的片剂,其配方以中医基础理论为指导,同时结合现代药理研究,确保产品的功效;本发明提供的调节高血糖的片剂,其加入玉米淀粉,于服用的片剂制剂,提高产品的生物利用度,适合血糖偏高者服用,且便于携带和运输;本发明提供的调节高血糖的片剂,此配方经过体内降糖动物功效验证,证明此配方具有显著降低高血糖的功效;本发明提供的调节高血糖的片剂,其方中精选各药为国家规定的药食同源原料,且用量上严格限制在一定范围(药典用量下限的2/3),安全有效,无毒副作用,可长期食用;本发明提供的调节高血糖的片剂,可预防糖尿病疾病,控制血糖,保护胰岛细胞,调节血脂,尤其对中老年人血糖偏高者,三高患者,具有显著功效;本发明提供的调节高血糖的功能性食品及其制备方法,其通过特定的有效成分,制备成具调节高血糖,生物利用度高,且便于携带和运输的片剂。
对上述各个实施例得到的调节血糖的功能性食品的性能测试(每天早中晚各食用一次),详细结果见下表。
实验 | 食用量/ml | 食用天数 | 降血糖率(%) |
实施例1 | 500ml | 8 | 89.8% |
实施例2 | 480ml | 7 | 91.6% |
实施例3 | 520ml | 9 | 89.6% |
实施例4 | 500ml | 10 | 71.3% |
Claims (6)
1.一种调节血糖的功能性食品,其特征在于:所述功能性食品包括以下份数的有效成分:金耳8-12份、桑叶10-12份、白果12-16份、葛根8-12份、银杏叶15-20份、苦荞2-8份、人参2-12份。
2.根据权利要求1所述一种调节血糖的功能性食品,其特征在于:所述功能性食品包括以下份数的有效成分:金耳10份、桑叶11份、白果14份、葛根10份、银杏叶18份、苦荞5份、人参7份。
3.根据权利要求1-2所述一种调节血糖的功能性食品的制备方法,其特征在于:
步骤1、根据配合比和制造量选择适当量的金耳、桑叶、白果、葛根、银杏叶、苦荞、人参;
步骤2、将上述桑叶、葛根、苦荞去杂,然后用乙醇回流提取,收集滤液,浓缩,得浸膏1;
步骤3、以固体金耳实体为对象,采用纤维素酶提取方法,获得金耳发酵液(为多糖);
步骤4、将白果、银杏叶去杂,乙醇提取,收集滤液,浓缩,得浸膏2;
步骤5、将上述浸膏1、金耳发酵液、浸膏2混合均匀,比重控制在0.8-1.2,后进行喷雾干燥,得混合提取物;
步骤6、将人参去杂质,切断,用粉碎仪进行粉碎,粉末过80目筛网;
步骤7、将人参粉末、浸膏1、金耳发酵液及浸膏2混合,制成降糖片剂及降糖固体饮品功能食品。
4.根据权利要求3所述一种调节血糖的功能性食品的制备方法,其特征在于:所述步骤(2)中的水煮法提取桑叶、葛根、苦荞有效成分的具体步骤为:
(2.1)将桑叶、葛根、苦荞三种原料按特定比例取料,置多功能提取罐中;
(2.2)在多功能提取罐中加75%乙醇,料液比为1:8:13,浸泡1-2h;
(2.3)加温至沸腾,提取2次,1.5h/次;
(2.4)过滤,收集滤液,65℃减压浓缩,得浸膏1。
5.根据权利要求3所述一种调节血糖的功能性食品的制备方法,其特征在于:所述步骤(4)的醇提法提取白果、银杏叶的有效成分的具体步骤为:
(4.1)白果、银杏叶两种原料按特定比例取料,置多功能提取罐中;
(4.2)在多功能提取罐中加入75%乙醇,料液比为1:8,浸泡0.5-1h;
(4.3)加温至沸腾,提取3次,1.5h/次;
(4.4)过滤,收集滤液,65℃减压浓缩,得浸膏2。
6.根据权利要求3所述一种调节血糖的功能性食品的制备方法,其特征在于:
(a)将六种原料制备的粉状物86份,混合均匀,加入75份玉米淀粉、45份麦芽糊精、0.5份羟丙甲基纤维素混合均匀;
(b)称取4.5份羟丙甲基纤维素加入90%乙醇制成10%的羟丙甲基纤维素溶液,备用;
(c)将(a)中混合粉末加入(b)中粘合剂,14目筛网制粒;
(d)烘箱温度调至55℃,干燥1-3h;
(e)干燥颗粒于14目筛网进行整粒,后外加2份硬脂酸镁和2份二氧化硅,进行总混;
(f)颗粒进行压片,调整片重为0.6g/片,进行薄膜包衣,铝塑包装,即得调节高血糖片剂功能食品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911043632.5A CN110801469A (zh) | 2019-10-30 | 2019-10-30 | 一种调节血糖的功能性食品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911043632.5A CN110801469A (zh) | 2019-10-30 | 2019-10-30 | 一种调节血糖的功能性食品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110801469A true CN110801469A (zh) | 2020-02-18 |
Family
ID=69489750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911043632.5A Pending CN110801469A (zh) | 2019-10-30 | 2019-10-30 | 一种调节血糖的功能性食品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110801469A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111944698A (zh) * | 2020-07-24 | 2020-11-17 | 江苏大学 | 一种麦角甾醇过氧化物的生物发酵制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101822373A (zh) * | 2010-04-13 | 2010-09-08 | 江苏大学 | 金耳银杏功能性食品、制备方法及用途 |
CN103125942A (zh) * | 2013-03-22 | 2013-06-05 | 通化万嘉生物科技有限公司 | 人参苦荞麦功能食品及其制备方法 |
CN109549971A (zh) * | 2017-09-26 | 2019-04-02 | 东莞自然衡健康科技有限公司 | 一种调节高血糖的功能性食品及其制备方法 |
-
2019
- 2019-10-30 CN CN201911043632.5A patent/CN110801469A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101822373A (zh) * | 2010-04-13 | 2010-09-08 | 江苏大学 | 金耳银杏功能性食品、制备方法及用途 |
CN103125942A (zh) * | 2013-03-22 | 2013-06-05 | 通化万嘉生物科技有限公司 | 人参苦荞麦功能食品及其制备方法 |
CN109549971A (zh) * | 2017-09-26 | 2019-04-02 | 东莞自然衡健康科技有限公司 | 一种调节高血糖的功能性食品及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111944698A (zh) * | 2020-07-24 | 2020-11-17 | 江苏大学 | 一种麦角甾醇过氧化物的生物发酵制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101773081B1 (ko) | 저분자 사포닌 함량이 증대된 돌외 발효 추출물의 제조방법 | |
KR20100105346A (ko) | 녹용, 산수유, 당귀, 구기자, 산약, 진피, 천마, 배초향, 계피, 홍삼, 및 오미자의 추출물을 유효성분으로 포함하는 면역증강 조성물 | |
CN101612315A (zh) | 一种用于调整人体机能的中药复方制剂 | |
CN112336815A (zh) | 一种强体防癌调理三高抗衰老组合物及其应用 | |
CN101181351A (zh) | 一种抗疲劳、增强免疫的中药组合物及其制备方法 | |
CN108578544A (zh) | 一种具有降糖作用的中药组合物及其制备方法与应用 | |
KR100947278B1 (ko) | 하엽 추출물을 주성분으로 하는 탄수화물 및 지방 흡수억제 활성을 가지는 생약 조성물과 이의 제조 방법 | |
US20190000905A1 (en) | Gynostemma pentaphyllum fermented extracts comprising Saponins as an active functional food ingredient and preparation method thereof | |
CN106176953A (zh) | 一种包含青钱柳叶、罗汉果和桑叶的降血糖保健组合物 | |
KR101246689B1 (ko) | 식물혼합추출물을 함유하는 항당뇨용 조성물 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN110801469A (zh) | 一种调节血糖的功能性食品及其制备方法 | |
KR101094157B1 (ko) | 식물생약재를 이용한 당뇨개선용 건강보조식품 | |
CN101336965B (zh) | 一种用于改善糖耐量、降低血糖的中成药及其制备方法 | |
KR20130074119A (ko) | 초음파 처리를 이용한 인삼 프로사포게닌 고농도 함유 인삼 잎 및 줄기 제제 및 이의 제조방법 | |
CN115137770A (zh) | 一种具有降血脂血压功效的中药产品制作方法 | |
CN114404517A (zh) | 一种用于痛风和降低尿酸的组合物及其用途与制备方法 | |
CN108685964B (zh) | 毛大丁草提取物的应用及其有效组分制备方法 | |
CN112402569A (zh) | 一种抗疲劳保健品及其制备方法 | |
CN111888431A (zh) | 一种治疗糖尿病的组合物及其制备方法 | |
CN109123655A (zh) | 一种具有三高人群代餐调节功能的特医食品及制备方法 | |
KR101671571B1 (ko) | 당 흡수 저해용 인삼 씨 조성물 및 이것의 제조방법 | |
KR102675725B1 (ko) | 백작약 및 육계를 포함하는 항염증 및 면역 증강용 한방 환 조성물 및 이의 제조방법 | |
CN104740345B (zh) | 治疗糖尿病的中药组合物及其制备方法 | |
CN108553559B (zh) | 一种用于防治ⅱ型糖尿病的蔬果提取物配方及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200218 |
|
RJ01 | Rejection of invention patent application after publication |